These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7829086)

  • 21. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J
    Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9.
    Bergman W; Gruis NA; Sandkuijl LA; Frants RR
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):122S-125S. PubMed ID: 7963673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage mapping of melanoma (MLM) using 172 microsatellite markers.
    Nancarrow DJ; Walker GJ; Weber JL; Walters MK; Palmer JM; Hayward NK
    Genomics; 1992 Dec; 14(4):939-47. PubMed ID: 1478674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic heterogeneity in familial malignant melanoma.
    MacGeoch C; Bishop JA; Bataille V; Bishop DT; Frischauf AM; Meloni R; Cuzick J; Pinney E; Spurr NK
    Hum Mol Genet; 1994 Dec; 3(12):2195-200. PubMed ID: 7881419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s).
    Petty EM; Gibson LH; Fountain JW; Bolognia JL; Yang-Feng TL; Housman DE; Bale AE
    Am J Hum Genet; 1993 Jul; 53(1):96-104. PubMed ID: 8317504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
    Gruis NA; van der Velden PA; Sandkuijl LA; Prins DE; Weaver-Feldhaus J; Kamb A; Bergman W; Frants RR
    Nat Genet; 1995 Jul; 10(3):351-3. PubMed ID: 7670475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
    Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
    Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and physical map of the interferon region on chromosome 9p.
    Fountain JW; Karayiorgou M; Taruscio D; Graw SL; Buckler AJ; Ward DC; Dracopoli NC; Housman DE
    Genomics; 1992 Sep; 14(1):105-12. PubMed ID: 1385297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous deletions within human chromosome band 9p21 in melanoma.
    Fountain JW; Karayiorgou M; Ernstoff MS; Kirkwood JM; Vlock DR; Titus-Ernstoff L; Bouchard B; Vijayasaradhi S; Houghton AN; Lahti J
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10557-61. PubMed ID: 1438246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
    Jönsson G; Bendahl PO; Sandberg T; Kurbasic A; Staaf J; Sunde L; Crüger DG; Ingvar C; Olsson H; Borg A
    J Natl Cancer Inst; 2005 Sep; 97(18):1377-82. PubMed ID: 16174859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genome screen of 35 bipolar affective disorder pedigrees provides significant evidence for a susceptibility locus on chromosome 15q25-26.
    McAuley EZ; Blair IP; Liu Z; Fullerton JM; Scimone A; Van Herten M; Evans MR; Kirkby KC; Donald JA; Mitchell PB; Schofield PR
    Mol Psychiatry; 2009 May; 14(5):492-500. PubMed ID: 18227837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred.
    Hunt SC; Hopkins PN; Bulka K; McDermott MT; Thorne TL; Wardell BB; Bowen BR; Ballinger DG; Skolnick MH; Samuels ME
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1089-93. PubMed ID: 10764678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
    Goldstein AM; Fraser MC; Struewing JP; Hussussian CJ; Ranade K; Zametkin DP; Fontaine LS; Organic SM; Dracopoli NC; Clark WH
    N Engl J Med; 1995 Oct; 333(15):970-4. PubMed ID: 7666916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary cutaneous melanoma.
    Platz A; Ringborg U; Hansson J
    Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.
    Teerlink CC; Huff C; Stevens J; Yu Y; Holmen SL; Silvis MR; Trombetti K; Zhao H; Grossman D; Farnham JM; Wen J; Facelli JC; Thomas A; Babst M; Florell SR; Meyer L; Zone JJ; Leachman S; Cannon-Albright LA
    J Natl Cancer Inst; 2018 Dec; 110(12):1380-1385. PubMed ID: 29659923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci?
    Lohmann-Hedrich K; Neumann A; Kleensang A; Lohnau T; Muhle H; Djarmati A; König IR; Pramstaller PP; Schwinger E; Kramer PL; Ziegler A; Stephani U; Klein C
    Neurology; 2008 Feb; 70(9):686-94. PubMed ID: 18032746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
    Grimmond SM; Palmer JM; Walters MK; Scott C; Nancarrow DJ; Teh BT; Elmes C; Pyke C; Khoo SK; Bennett I; Wetzig N; Hayward NK
    Hum Genet; 1996 Jul; 98(1):80-5. PubMed ID: 8682513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline p16 mutations in familial melanoma.
    Hussussian CJ; Struewing JP; Goldstein AM; Higgins PA; Ally DS; Sheahan MD; Clark WH; Tucker MA; Dracopoli NC
    Nat Genet; 1994 Sep; 8(1):15-21. PubMed ID: 7987387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
    Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
    Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.